What we measure

The 2021 AMR Benchmark evaluates how 17 pharmaceutical companies are responding to the global threat of AMR. It has examined company actions relating to medicines and vaccines for bacterial and fungal infections. Find out more about the research scopes.


Get in touch

Back to top |